Drug recall D-1528-2016
Product
PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.
Lots and codes
Lot # M35953S; Exp. 11/17 (labeled).
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 1,316 bottles (1,316,000 tablets)
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 15, 2016
- Terminated
- August 9, 2017
Related products
- Premarin – drug information
- NDC 0046-1100 Premarin · Estrogens, Conjugated .3 mg/1 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- NDC 0046-1102 Premarin · Estrogens, Conjugated .625 mg/1 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- NDC 0046-1104 Premarin · Estrogens, Conjugated 1.25 mg/1 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- NDC 0046-1101 Premarin · Estrogens, Conjugated .45 mg/1 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- NDC 0046-1103 Premarin · Estrogens, Conjugated .9 mg/1 · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.